Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 21

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Comparative efficacy of medicaments or techniques for pulpotomy of primary molars: a network meta-analysis

Guo, Jiehua, Zhang, Na, Cheng, Yuzhao · 2022 · Clinical Oral Investigations

Abstract

Objectives: We performed this network meta-analysis to determine the comparative efficacy of formocresol (FC), ferric sulfate (FS), sodium hypochlorite (NaOCl), calcium hydroxide (CH), mineral trioxide aggregate (MTA), biodentine, and laser for pulpotomy of molar teeth. Materials and methods: An updated search was conducted in PubMed, Embase, and the Cochrane Library to identify relevant randomized controlled trials (RCTs) published before October 30, 2022, after screening previous meta-analyses. The Cochrane risk of bias assessment tool was used to appraise the methodological quality of included studies. Clinical and radiographic success rates were assessed as outcomes. Random network meta-analysis was performed by using STATA software (version 14.0) with “network” command. Results: A total of 43 RCTs were included. Network meta-analysis indicated that CH was inferior to other medicaments and techniques in all outcomes, and MTA and biodentine was better than FC, FS, and NaOCl in terms of clinical and radiographic success rates. Results of ranking probabilities suggested that MTA ranked first in all outcomes except for clinical success at both 6 months. Conclusions: Our results suggested that MTA was associated with significant improvement in both clinical and radiographic success than other pulpotomy medicaments and techniques, with the highest probability of being the optimal option. Clinical relevance: The current network meta-analysis determined the comparative efficacy and safety of 7 common pulpotomy medicaments in molar pulpotomy, including FC, FS, NaOCl, CH, MTA, biodentine, and laser, and the pooled results revealed comparable efficacy in clinical and radiographic success rates at 6 and 12 months between FC, FS, and NaOCl in primary molars pulpotomies. However, MTA, biodentine and laser may have more advantages than other pulpotomy medicaments for clinical and radiographic success. Therefore, in clinical practice, practitioners should select MTA, biodentine, or laser as pulpotomy medicaments in molar pulpotomy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00784-022-04830-1

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 68

  1. Ranly DM (1994) Pulpotomy therapy in primary teeth: new modalities for old rationales. Pediatr Dent 16(6):403–409
  2. Ansari G, Morovati SP, Asgary S (2018) Evaluation of four pulpotomy techniques in primary molars: a randomized controlled trial. Iran Endod J 13(1):7–12
  3. Noorollahian H (2008) Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. Br Dent J 204(11):E20 · doi:10.1038/sj.bdj.2008.319
  4. Fuks AB, Eidelman E (1991) Pulp therapy in the primary dentition. Curr Opin Dent 1(5):556–563
  5. Fuks AB (2008) Vital pulp therapy with new materials for primary teeth: new directions and Treatment perspectives. Pediatr Dent 30(3):211–219
  6. Smaïl-Faugeron V et al (2018) Pulp treatment for extensive decay in primary teeth. Cochrane Database Syst Rev 5(5):Cd003220
  7. Al-Dlaigan YH (2015) Pulpotomy medicaments used in deciduous dentition: an update. J Contemp Dent Pract 16(6):486–503 · DOI
  8. Buckley JP (1904) The chemistry of pulp deposition with a rational treatment for this condition and its sequelae. Am Dent J 3:764
  9. Fuks AB et al (1997) Pulp response to ferric sulfate, diluted formocresol and IRM in pulpotomized primary baboon teeth. ASDC J Dent Child 64(4):254–259
  10. Ramanandvignesh P, Kumar G, Mridula D (2020) Clinical and radiographic evaluation of pulpotomy using mta, biodentine and Er, Cr: YSGG laser in primary teeth- a clinical study. Laser Ther 29(1):29–34 · DOI · Paper page
  11. Bossù M, Iaculli F, Di Giorgio G, Salucci A, Polimeni A, Di Carlo S (2020) Different pulp dressing materials for the pulpotomy of primary yeeth: a systematic review of the literature. J Clin Med 9(3):838 · doi:10.3390/jcm9030838
  12. Chandran V et al (2020) Effect of Laser therapy vs conventional techniques on clinical and radiographic outcomes of deciduous molar pulpotomy: a systematic review and meta-analysis. J Clin Exp Dent 12(6):e588–e596 · doi:10.4317/jced.56436
  13. Jayaraman J et al (2020) Effectiveness of formocresol and ferric sulfate as pulpotomy material in primary molars: a systematic review and meta-analysis with trial sequential analysis of randomized clinical trials. Quintessence Int (Berlin, Germany: 1985) 51(1):38–48
  14. Deery C (2005) Formocresol and ferric sulfate have similar success rates in primary molar pulpotomy. In carious primary molars does a pulpotomy performed with ferric sulphate, compared with formocresol, result in greater clinical/radiographic success? Evid Based Dent 6(3):70 · doi:10.1038/sj.ebd.6400348
  15. Peng L et al (2007) Evaluation of formocresol versus ferric sulphate primary molar pulpotomy: a systematic review and meta-analysis. Int Endod J 40(10):751–757 · DOI
  16. Jayaraman J et al (2020) Effectiveness of formocresol and ferric sulfate as pulpotomy material in primary molars: a systematic review and meta-analysis with trial sequential analysis of randomized clinical trials. Quintessence Int 51(1):38–48
  17. Nuvvula S, Bandi M, Mallineni SK (2018) Efficacy of ferric sulphate as a pulpotomy medicament in primary molars: an evidence based approach. Eur Arch Paediatr Dent 19(6):439–447 · DOI
  18. Lin PY et al (2014) Primary molar pulpotomy: a systematic review and network meta-analysis. J Dent 42(9):1060–1077 · DOI
  19. Tewari N, Goel S, Mathur VP, O'Connell AC, Johnson RM, Rahul M, Sultan F, Goswami M, Srivastav S, Ritwik P (2022) Success of medicaments and techniques for pulpotomy of primary teeth: an overview of systematic reviews. Int J Paediatr Dent 32(6):828–842 · DOI
  20. Dias S, Caldwell DM (2019) Network meta-analysis explained. Arch Dis Child Fetal Neonatal Ed 104(1):F8-f12 · DOI · Paper page
  21. Hutton B et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777–784 · DOI · Paper page
  22. Higgins JP et al (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928 · DOI · Paper page
  23. Tu YK (2015) Using generalized linear mixed models to evaluate inconsistency within a network meta-analysis. Value Health 18(8):1120–1125 · DOI
  24. Yu-Kang T (2016) Node-splitting generalized linear mixed models for evaluation of inconsistency in network meta-analysis. Value Health 19(8):957–963 · DOI
  25. Lu G, Ades AE (2006) Assessing evidence inconsistency in mixed treatment comparisons. J Am Stat Assoc 101(474):447–459 · DOI · Paper page
  26. Palma Perez S, Delgado Rodriguez M (2006) Practical considerations on detection of publication bias. Gac Sanit 20(20 Suppl 3):10–6 · DOI
  27. Al-Mutairi MA, Bawazir OA (2013) Sodium hypochlorite versus Formocresol in primary molars pulpotomies: a randomized clinical trial. Eur J Paediatr Dent 14(1):33–36
  28. Atasever G et al (2019) Primary molar pulpotomies with different hemorrhage control agents and base materials: a randomized clinical trial. Niger J Clin Pract 22(3):305–312 · doi:10.4103/njcp.njcp_369_18
  29. Chauhan SP et al (2017) Evaluation and comparison between formocresol and sodium hypochlorite as pulpotomy medicament: a randomized study. J Contemp Dent Pract 18(11):1029–1033 · doi:10.5005/jp-journals-10024-2170
  30. Erdem AP et al (2011) Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study. Pediatr Dent 33(2):165–170
  31. Farrokh Gisoure E (2011) Comparison of three pulpotomy agents in primary molars: a randomised clinical trial. Iran Endod J 6(1):11–14
  32. Farsi DJ et al (2015) Sodium hypochlorite versus formocresol and ferric sulfate pulpotomies in primary molars: 18-month follow-up. Pediatr Dent 37(7):535–540
  33. Fei AL, Udin RD, Johnson R (1991) A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatr Dent 13(6):327–332
  34. Fernández CC et al (2013) Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2-year follow-up. Int J Paediatr Dent 23(6):400–407 · doi:10.1111/ipd.12009
  35. Huth KC et al (2012) Long-term effectiveness of four pulpotomy techniques: 3-year randomised controlled trial. Clin Oral Investig 16(4):1243–1250 · DOI · Paper page
  36. Ildeş GÇ, Sezgin BI, Vieira AR, Mentes A (2022) A randomized clinical trial of hyaluronic acid gel pulpotomy in primary molars with 1 year follow-up. Acta Odontol Scand 80(4):273–280 · doi:10.1080/00016357.2021.1998612
  37. Ruby JD et al (2013) A randomized study of sodium hypochlorite versus formocresol pulpotomy in primary molar teeth. Int J Paediatr Dent 23(2):145–152 · doi:10.1111/j.1365-263x.2012.01237.x
  38. Shabzendedar M et al (2013) Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1-year follow-up. Pediatr Dent 35(4):329–332
  39. Sonmez D, Sari S, Cetinbaş T (2008) A comparison of four pulpotomy techniques in primary molars: a long-term follow-up. J Endod 34(8):950–955 · doi:10.1016/j.joen.2008.05.009
  40. Vargas KG, Packham B, Lowman D (2006) Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatr Dent 28(6):511–517
  41. Haideri S et al (2021) To evaluate and compare the clinical and radiographic outcomes of formocresol, mineral trioxide aggregate, electrocautery, and bioactive glass when used for pulpotomy in human primary teeth. J Pharm Bioallied Sci 13(6):S1251–S1258 · doi:10.4103/jpbs.jpbs_23_21
  42. Cordell S et al (2021) A randomized controlled trial comparing the success of mineral trioxide aggregate and ferric sulfate as pulpotomy medicaments for primary molars. J Dent Child (Chicago, Ill.) 88(2):120–128
  43. Abuelniel GM et al (2021) Evaluation of mineral trioxide aggregate and biodentine as pulpotomy agents in immature first permanent molars with carious pulp exposure: a randomised clinical trial. Eur J Paediatr Dent 22(1):19–25
  44. Abd Al Gawad RY, Hanafy RMH (2021) Success rate of three capping materials used in pulpotomy of primary molars: a randomized clinical trial. Saudi Dent J 33(7):560–567 · doi:10.1016/j.sdentj.2020.08.007
  45. Pei SL, Shih WY, Liu JF (2020) Outcome comparison between diode laser pulpotomy and formocresol pulpotomy on human primary molars. J Dent Sci 15(2):163–167 · doi:10.1016/j.jds.2020.03.005
  46. Lin Y-T, Lin Y-TJ (2020) Success rates of mineral trioxide aggregate, ferric sulfate, and sodium hypochlorite pulpotomies: a prospective 24-month study. J Formos Med Assoc 119(6):1080–1085 · doi:10.1016/j.jfma.2019.10.004
  47. Alamoudi N et al (2020) Clinical and radiographic success of low-level laser therapy compared with formocresol pulpotomy treatment in primary molars. Pediatr Dent 42(5):359–366
  48. Ahuja S et al (2020) Comparative Evaluation of success of biodentine and mineral trioxide aggregate with formocresol as pulpotomy medicaments in primary molars: an in vivo study. Int J Clin Pediatr Dent 13(2):167–173 · DOI · Paper page
  49. Abuelniel GM, Duggal MS, Kabel N (2020) A comparison of MTA and Biodentine as medicaments for pulpotomy in traumatized anterior immature permanent teeth: a randomized clinical trial. Dent Traumatol 36(4):400–410 · doi:10.1111/edt.12553
  50. Mythraiye R et al (2019) Evaluation of the clinical and radiological outcomes of pulpotomized primary molars treated with three different materials: mineral trioxide aggregate, biodentine, and pulpotec. an in-vivo study. Cureus 11(6):e4803
  51. El Meligy O et al (2019) BiodentineTM versus formocresol pulpotomy technique in primary molars: a 12-month randomized controlled clinical trial. BMC Oral Health 19(1):3 · DOI
  52. Çelik BN et al (2019) The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth. Clin Oral Invest 23(2):661–666 · DOI · Paper page
  53. Nematollahi H et al (2018) Mineral trioxide aggregate partial pulpotomy versus formocresol pulpotomy: a randomized, split-mouth, controlled clinical trial with 24 months follow-up. Pediatr Dent 40(3):184–189
  54. Junqueira MA et al (2018) Clinical, radiographic and histological evaluation of primary teeth pulpotomy using MTA and ferric sulfate. Braz Dent J 29(2):159–165 · DOI
  55. Rajasekharan S et al (2017) Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. Int Endod J 50(3):215–228 · doi:10.1111/iej.12619
  56. Juneja P, Kulkarni S (2017) Clinical and radiographic comparison of biodentine, mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars. Eur Arch Paediatr Dent: Off J Eur Acad Paediatr Dent 18(4):271–278 · doi:10.1007/s40368-017-0299-3
  57. Carti O, Oznurhan F (2017) Evaluation and comparison of mineral trioxide aggregate and biodentine in primary tooth pulpotomy: clinical and radiographic study. Niger J Clin Pract 20(12):1604–1609 · DOI · Paper page
  58. Cuadros-Fernández C et al (2016) Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and biodentine: a randomized clinical trial. Clin Oral Invest 20(7):1639–1645 · DOI
  59. Olatosi OO, Sote EO, Orenuga OO (2015) Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study. Niger J Clin Pract 18(2):292–296 · DOI
  60. Kusum B, Rakesh K, Richa K (2015) Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restor Dent Endod 40(4):276–285 · doi:10.5395/rde.2015.40.4.276
  61. Gupta G et al (2015) Laser pulpotomy-an effective alternative to conventional techniques: a 12 months clinicoradiographic study. Jaypees Int J Clin Pediatr Dent 8(1):18–21
  62. Oliveira TM et al (2013) Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. Eur Arch Paediatr Dent 14(2):65–71 · DOI · Paper page
  63. Sushynski JM et al (2012) Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6- to 24-month observation. Pediatr Dent 34(5):120–128
  64. Srinivasan D, Jayanthi M (2011) Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth. Indian J Dent Res 22(3):385–390 · doi:10.4103/0970-9290.87058
  65. Zealand CM et al (2010) Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars. Pediatr Dent 32(5):393–399
  66. Alaçam A et al (2009) Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108(5):e127–e133 · DOI
  67. Hemavathi et al (2018) Clinical and radiographic evaluation of the efficacy of sodium hypochlorite as a haemostatic agent compared with physiologic saline on the success of calcium hydroxide pulpotomies in primary molars: an in vivo study. Eur Arch Paediatr Dent 19(6):423–430 · doi:10.1007/s40368-018-0377-1
  68. Miller PD et al (2016) Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab 101(8):3163–3170 · DOI · Paper page

Cited by

See all 21

Metadata

Authors
Guo, J., Zhang, N., & Cheng, Y.
Venue
Clinical Oral Investigations
Published
2022-12-29
Volume
27
Issue
1
Pages
91-104
ISSN
1436-3771
Cited by
21
References
5
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.